GlassScriptPhysician profile
Vanda L Davidson
NPI 1508858184
$772.69
in general payments reported to CMS, 2019-2025
23 companies · $18.63 in 2025
The $18.63 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2020: $210 · 2021: $202 · 2022: $131 · 2024: $64.36 · 2025: $18.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $82.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $82.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $90.93 | 2019-2024 | Exogen Ultrasound Bone Healing System |
| Lilly USA, LLC | $80.61 | 2019-2021 | |
| Abbvie INC. | $75.74 | 2020-2021 | |
| Genzyme Corporation | $74.86 | 2020 | |
| Davol INC. | $56.10 | 2022 | |
| Celgene Corporation | $53.75 | 2019 | |
| Radius Health, INC. | $46.19 | 2020-2021 | |
| Janssen Biotech, INC. | $30.66 | 2020-2021 | |
| Innovation Technologies INC | $29.31 | 2024 | Irrisept |
| Ultragenyx Pharmaceutical INC. | $21.44 | 2021 | |
| Ucb, INC. | $19.62 | 2021 | |
| Avanos Medical | $19.09 | 2022 | |
| Molnlycke Health Care US, LLC | $18.63 | 2025 | Mepilex Border Post-Op Ag, Mepilex Border Post-Op |
| Becton, Dickinson and Company | $17.60 | 2019 | |
| Fidia Pharma USA INC. | $17.28 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $16.65 | 2021 | |
| Stryker Corporation | $16.30 | 2021 | |
| Pfizer INC. | $16.26 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $16.19 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $15.90 | 2022 | |
| Kci USA, INC. | $13.38 | 2022 | |
| Zyla Life Sciences, INC. | $13.19 | 2019 | |
| Novartis Pharmaceuticals Corporation | $13.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vanda Davidson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.